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Atm-dependent interactions of a mammalian Chk1 homolog with
meiotic chromosomes
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Background: Checkpoint pathways prevent cell-cycle progression in the event
of DNA lesions. Checkpoints are well defined in mitosis, where lesions can be
the result of extrinsic damage, and they are critical in meiosis, where DNA
breaks are a programmed step in meiotic recombination. In mitotic yeast cells,
the Chk1 protein couples DNA repair to the cell-cycle machinery. The Atm and
Atr proteins are mitotic cell-cycle proteins that also associate with chromatin
during meiotic prophase I. The genetic and regulatory interaction between Atm
and mammalian Chk1 appears to be important for integrating DNA-damage
repair with cell-cycle arrest.
Results: We have identified structural homologs of yeast Chk1 in human and
mouse. Chk1Hu/Mo has protein kinase activity and is expressed in the testis.
Chk1 accumulates in late zygotene and pachytene spermatocytes and is
present along synapsed meiotic chromosomes. Chk1 localizes along the
unsynapsed axes of X and Y chromosomes in pachytene spermatocytes. The
association of Chk1 with meiotic chromosomes and levels of Chk1 protein
depend upon a functional Atm gene product, but Chk1 is not dependent upon
p53 for meiosis I functions. Mapping of CHK1 to human chromosomes
indicates that the gene is located at 11q22–23, a region marked by frequent
deletions and loss of heterozygosity in human tumors.
Conclusions: The Atm-dependent presence of Chk1 in mouse cells and along
meiotic chromosomes, and the late pachynema co-localization of Atr and Chk1
on the unsynapsed axes of the paired X and Y chromosomes, suggest that
Chk1 acts as an integrator for Atm and Atr signals and may be involved in
monitoring the processing of meiotic recombination. Furthermore, mapping of
the CHK1 gene to a region of frequent loss of heterozygosity in human tumors
at 11q22–23 indicates that the CHK1 gene is a candidate tumor suppressor
gene.
Background
Programmed DNA strand breaks initiate meiotic recombi-
nation and are an essential component of meiosis [1–3].
Many DNA repair and cell-cycle checkpoint proteins are
required for completion of meiosis [4]. In somatic cells,
proliferation is arrested in response to DNA damage and,
in model organisms, radiation-sensitive mutants have
been identified that are defective in coupling DNA
damage detection to control of cell-cycle progression
[5–7]. The process of monitoring genome integrity and
preventing cell-cycle progress is the DNA damage check-
point [8], where signal transduction cascades couple
damage detection to cell-cycle progression. 
In Saccharomyces cerevisiae, meiotic recombination is initi-
ated by DNA double-strand breaks. Processing of the
recombination intermediates is controlled by proteins that
were originally identified as the products of DNA repair or
mitotic checkpoint genes. In mammalian cells, homologs
of several checkpoint proteins have been identified,
including Atr and Atm, which share significant structural
homology with the yeast Rad3/Mec1 and Tel1 proteins
respectively [9–14]. The Rad3 and Mec1p proteins acti-
vate DNA-damage response pathways by sensing lesions
affecting genomic integrity [15–18]. Atm is involved
directly in the mammalian DNA damage responses, and
Atm-defective cells do not halt cell-cycle progression in
the presence of DNA lesions [19]. 
Failure to repair DNA damage or to arrest cell-cycle pro-
gression appropriately may contribute to genetic instabil-
ity and cancer [6]. Atm and p53 are important regulators in
somatic cells for DNA-damage checkpoint control and
maintenance of genomic stability [20–23]. In addition,
many other checkpoint and DNA-repair proteins are
essential for meiosis. In S. cerevisiae, Mec1p has a role in
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meiosis I and the esr1-1 allele of MEC1 confers a defect in
meiotic recombination [18]. In Drosophila, Mei-41 encodes
an Atr homolog [24] and mei-41 mutant flies have reduced
meiotic recombination frequencies and aberrant recombi-
nation nodules [25]. Likewise, atm–/– mice are infertile and
show significant synaptonemal complex fragmentation
[20–22]. Consistent with the atm–/– genetic defect, the Atm
kinase associates with the lateral elements of the synap-
tonemal complex during meiotic prophase I [10]. 
The DNA-damage signal transduction cascade that feeds
into the cell-cycle machinery has been best characterized
in model organisms. Following a Rad3-dependent step,
the coupling of repair to the mitotic cell-cycle machinery
is mediated by Chk1 [26–29]. Chk1 is a protein kinase
that effects the mitotic arrest that follows DNA damage
but is not required for other checkpoint-mediated
responses such as the mitotic arrest that occurs in response
to DNA replication defects. In Drosophila, a Chk1 homolog
called grapes (Grp) acts downstream of Mei-41, a Mec1
homolog [24,30,31]. Grp mediates the mid-blastula transi-
tion [30] and genetically acts upstream of string, which
encodes a cdc25 phosphatase homolog [30,31]. Further,
protein kinase signals from Grp impinge onto phosphory-
lation of cdc2 protein [31], suggesting a signaling pathway
from Atr and Atm into Chk1 and cdc25 protein that affects
cdc2 protein and the cell-cycle machinery. Here, we report
the characterization of human and mouse Chk1 and the
role that Chk1 plays in meiotic recombination and Atm-
dependent signal transduction. An identical clone has
been reported [32] and this protein phosphorylates human
Cdc25 protein.
Results
Identification of CHK1Hu/Mo
A CHK1Hu cDNA was identified by screening expressed
sequence-tagged (EST) sequences for similarity to
Schizosaccharomyces pombe Chk1 coding sequence. A mouse
Chk1 sequence was identified by degenerate PCR, using
primers to conserved regions between human and S. pombe
Chk1, with a bias towards the human sequence. The
CHK1Hu and Chk1Mo sequences are approximately 90%
identical to each other through the protein kinase
domains. D. melanogaster Grp, a Caenorhabditis elegans EST,
S. pombe Chk1 and an S. cerevisiae open-reading frame show
44%, 33%, 23% and 20% identity, respectively, to CHK1Hu
in the protein kinase domain (see Figure S1, Supplemen-
tary material). CHK1Hu was sublocalized to human chro-
mosome 11q23.3, a region that shows loss of
heterozygosity (LOH) in a significant proportion of human
tumors [33–39]. The CHK1Hu reported here is identical to
that of Sanchez et al. [32].
Northern analysis was performed using the protein kinase
coding region from mouse and human CHK1 as a probe.
Chk1 RNA was detected in the thymus, lung and prostate
in human samples and in the lung and spleen in mouse
samples (see Figure S2, Supplementary material). Analysis
of RNA from mouse embryos revealed a transient increase
at day 11 of development. Testis RNA samples from
mouse and humans both showed elevated expression of
Chk1, suggesting that Chk1 may have a role in meiosis and
the development of sperm cells. 
Monospecific antipeptide antibodies were generated
against Chk1Hu/Mo (Figure 1a). The anti-Chk1Hu/Mo serum
detected mouse and human Chk1 in western analyses
(Figure 1a,b and see Figure 5) and could immunoprecipi-
tate Chk1 from mouse testis extract (Figure 1a). The reac-
tivity of the serum was blocked by the peptide
immunogen, was specific to post-immune serum, could
not be blocked by a non-Chk1 peptide of similar size
(Figure 1a, peptide 62) and recognized recombinant Chk1
(Figure 1b). The purified glutathione-S-transferase
(GST)–Chk1 fusion protein was active as a protein kinase
and was able to autophosphorylate and to phosphorylate
exogenous substrates such as myelin basic protein, MBP
(Figure 1c). The immunoprecipitated protein kinase
activity from human fibroblasts phosphorylates MBP
(Figure 1d). These data suggest that Chk1Hu/Mo has associ-
ated protein kinase activity and that the protein kinase
activity does not require a regulatory subunit.
Developmentally regulated Chk1 expression in mouse
testis is dependent upon Atr
In testis, pre-meiotic cells surround the surface of the sem-
iniferous tubules and progression towards the interior
lumen of a tubule corresponds to progressively later stages
of meiosis and sperm maturation (Figure 2a). Histological
analysis of testis sections with anti-Atr antibodies shows a
punctate pattern in zygotene nuclei [10]. Like Atr (Figure
2g), Chk1Mo shows nuclear staining in a ring of cells in
normal mouse testis seminiferous tubules (Figure 2b).
Chk1 is present in cells that are in the process of meiotic
prophase I. Chk1 is not detected in the peripheral cells in
seminiferous tubules that are undergoing pre-meiotic
DNA synthesis, nor is it observed in late condensing or
mature sperm. The process of meiosis in testes, as
observed in tissue slices, proceeds in a wave from the exte-
rior of the seminiferous tubule, and the staining pattern of
Chk1 in a band of cells within the tubule shows a temporal
increase and decrease in Chk1 expression. A quantitation
of Chk1 accumulation is given in Figure 3. Here, the
number of histologically positive cells was counted in a
representative sampling of tubules and the staining pattern
compared to that obtained for Atr [10]. Chk1Mo is most
highly expressed in pachytene cells in primary spermato-
cytes, suggesting that Chk1Mo may act temporally down-
stream of Atr, which acts earlier, during zygonema. 
Because Atm and p53 regulate checkpoints that have been
proposed to act genetically upstream of Chk1, the
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localization of Chk1Mo by histological analyses was exam-
ined in atm+/+ p53–/–, atm–/– p53+/+, atm–/– p53+/– and atm–/–
p53–/– mice [40,41]. Chk1Mo accumulation and localization
was independent of p53 status but dependent on that of
Atm (Figure 2c–f). It is formally possible that the lack of
Chk1 in the atm–/– background is due to a strain variation,
but we consider it more probable that Chk1 is Atm-depen-
dent, as the requirement for Atm segregates with crosses
into p53-null genetic backgrounds. The accumulation and
decrease in Chk1 is temporally coincident with that of Atr,
and anti-Chk1 staining is Atm-dependent. 
Chk1 localizes along the synaptonemal complex
To extend the analysis of Chk1 in testis, the temporal and
spatial distribution of Chk1 in spermatocyte surface-
spread preparations [42] was examined. In these analyses,
Scp3, a component of the axial/lateral elements of the
synaptonemal complexes [43], was used to monitor the
temporal progress of meiosis (Figure 4a). In normal mice,
Chk1 appears in a focal pattern along the autosomal
synaptonemal complexes of homologous chromosomes as
they synapse in zygonema (Figure 4b). Chk1 accumulates
along the synaptonemal complexes as meiosis proceeds
into pachynema and, by mid-pachynema, Chk1 coats the
entire synaptonemal complexes (Figure 4b). In early
pachynema, Chk1 is present along the synapsed regions of
the heteromorphic X–Y bivalent, but not along the un-
synapsed axes. However, by mid-pachynema, Chk1 foci
also appear along the unsynapsed region of the X–Y
bivalent (Figure 4c).
Atr localizes to discrete regions along unsynapsed chromo-
some axial elements in zygotene, including the un-
synapsed axes of the X–Y bivalent, and in the sex body
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Figure 1
Analysis of Chk1 proteins. (a) Chk1Mo was
immunoprecipitated from 400 µg of mouse
testis extracts using 10 µg affinity-purified
anti-Chk1 serum #2-3 (αChk1IP; lane 1) and
was detected by western analysis. The
specificity of the immunoprecipitate and
western analysis was compared to that of 
pre-immune serum, to peptide blocks of the
immune serum (peptide) and to a non-Chk1
peptide of similar molecular weight (peptide
62; MITIRGSVHQNFADFTFATGK in single-
letter amino-acid code). (b) Western analysis
of recombinant and human Chk1. Protease-
cleaved Gst–Chk1, rChk1 (5 ng) was
electrophoresed adjacent to 50 µg whole cell
lysate. Anti-Chk1 #2-3 recognizes the
recombinant protein and the natural human
protein. From its migration, the recombinant
protein appears to be around 5 kDa smaller
than natural Chk1. The CHK1Hu cDNA is
identical to that of Sanchez et al. [32]. This
cDNA is believed to be near full-length. The
GST–CHK1 cDNA uses the first methionine
in the sequence. However, the cDNA has an
extended 5′ open-reading frame that lacks a
stop codon [32] and the natural methionine
may be lacking. Alternatively, as shown in
[32], Chk1 is a phosphoprotein and the
difference in migration rates may be due to
modification differences. (c) Protein kinase
activity of Gst–Chk1Hu. Protein kinase activity
is specific to Gst–Chk1 using myelin basic
protein (MBP) as a substrate. GST–X is GST
protein purified from a vector control.
GST–Chk1 is the fusion protein of GST and
Chk1Hu. E is an E. coli lysate from a strain
without Gst or Chk1. The + or – denotes
whether MBP was added to the sample run in
that lane. (d) Protein kinase activity of Chk1Hu
immunoprecipitated from human fibroblasts
with the anti-Chk1 #2-3: pre-I, pre-immune
sera.
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(the chromatin surrounding the sex chromosomes) as
pachynema proceeds [10]. Because Chk1 foci also appear
along the unsynapsed axes of both the X and Y chromo-
somes during the later part of pachynema, the co-localiza-
tion of Atr and Chk1 was examined (Figure 4c).
Consistent with a previous report [10], Atr accumulates
along the X–Y bivalents as pachynema proceeds. By mid-
pachynema, Chk1 is also accumulating along the X–Y
bivalent axes where it co-localizes with Atr (Figure 4c).
To extend the analysis of Chk1 association with the
synaptonemal complex and to examine the lack of histo-
logically detectable Chk1 protein in atm–/– mice (Figure
2d–f), we examined the association of Chk1 with surface-
spread spermatocytes from various mouse mutant strains.
Meiosis appeared unaffected in p53-deficient mice. In
these mice, histological analysis and synaptonemal
complex analysis with Scp3 and Chk1 gave results indis-
tinguishable from wild type (p53+/+) mice (Figure 4d,e). In
contrast, atm–/– mice are sterile as a result of progressive
fragmentation of synaptonemal complex [20]. Immuno-
localization of Chk1 in atm–/– spermatocytes (Figure 4g)
980 Current Biology, Vol 7 No 12
Figure 2
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(e) atm–/– p53+/– αChk1 (f) atm–/– p53–/– αChk1 (g) atm+/+ p53+/+ αAtr
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Immunohistological characterization of Chk1Mo in the testis. 
(a) Diagrammatic representation of a cross-section of a seminiferous
tubule and the developmental progression leading to mature sperm
production (adapted with permission from [53]). (b–g) Histological
analysis of Chk1 and its expression in mouse testes in various genetic
backgrounds. Chk1 nuclear staining appears as brown foci in a ring of
cells around the inner seminiferous tubule. (b,g) Cross-sections of
wild-type mice (atm+/+ p53+/+) stained with anti-Chk1 (αChk1) in (b)
and anti-Atr (αAtr) in (g) [9]. (c) Section from a p53 mutant
homozygote (atm+/+ p53–/–) stained with anti-Chk1. (d) An atm
homozygote (atm–/– p53+/+) showing loss of detection of Chk1
staining. (e) An atm homozygote p53 heterozygote (atm–/– p53+/–)
showing loss of detection of Chk1 staining. (f) A double atm/p53
homozygote (atm–/– p53–/–) section showing loss of detection of Chk1
foci. The specificity of staining was confirmed by examining pre-
immune serum and by specific and non-specific peptide block
experiments (data not shown). Each panel shows a ×20 magnification
of mouse seminiferous tubules. Light purple staining reveals cells in
meiotic stages prior to sperm condensation. The densely stained cells
have completed the second meiotic division and are condensing or
mature spermatocytes.
Figure 3
Graphical summary of histological localization of Chk1 as compared
with Atr. The y-axis is the average of at least three representative
tubules and each stage of development is displayed on the x-axis.
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indicates a lack of Chk1 on the synaptonemal complexes.
A summary of these results is presented in Table 1.
To determine if the lack of Chk1 staining in atm–/– nuclei
(Figure 2d–f) and the lack of Chk1Mo protein on meiotic
prophase chromatin (Figure 4g) was reflected by the level
of Chk1Mo, western analysis of testis extracts was performed
(Figure 5). Chk1 protein was present in an Atm-dependent
fashion in testis extracts, suggesting that synthesis or stabil-
ity of Chk1Mo depends on the Atm protein.
Discussion
Chk1 acts temporally downstream from Atm
Precise staging of meiotic prophase events is possible
using well established cytological criteria, as meiosis in
male mammals occurs over several days [44–46]. In mouse
spermatocytes, zygonema (when pairing of homologous
chromosomes — synapsis — begins) takes about 24 hours,
and pachynema takes 6 days [44,45]. Pachynema is the
stage of meiotic prophase during which homologous chro-
mosomes are synapsed and during which meiotic recombi-
nation (crossing-over) occurs. Pachynema can be divided
into substages, which encompass from 1 to 3 days each.
Therefore, timing of meiotic prophase events is feasible,
and one can determine whether proteins are appearing
contemporaneously  or sequentially [45]. 
Cytological analysis using antibodies that recognize Atr,
Atm, Rad51, Mlh1 or Brca1 has shown that Rad51, Brca1
and Atr can associate with and form foci on unsynapsed
axes of meiotic chromosomes [10,45–47]. Atm and Rad51
associate with synapsed axes and Mlh1 forms foci late in
pachynema [46]. Since unsynapsed axes of autosomes are
present during zygonema and full chromosome synapsis
occurs during pachynema, the chromosomes can be staged
with an internal marker (Scp3 [48]), thus allowing accurate
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Figure 4
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Localization of Chk1 during meiotic prophase I. (a) Nucleus of
zygotene spermatocyte stained with an antiserum against Scp3
(αScp3), a component of the axial element [43]. (b) The same nucleus
counterstained with anti-Chk1 antibodies (αChk1). Chk1 is present
along the synaptonemal complex of synapsed homologous
chromosomes (arrowhead, green = Chk1 localization). Chromosomes
that are in the process of synapsing (large arrows) have Chk1 staining,
but staining is not observed on the unsynapsed axial elements (small
arrows). During pachynema (c), spermatocytes can be labeled with
both αChk1 and a mouse monoclonal antibody against Atr (224C, red
= Atr localization). Although Chk1 initially appears in a focal pattern, in
pachynema Chk1 accumulates along the synaptonemal complexes
(arrowhead). In addition, Chk1 foci appear along the unsynapsed axial
elements of the X and Y chromosomes in mid-pachynema where it co-
localizes with Atr (yellow = co-localization). (d,e) Early pachytene
p53–/– spermatocyte labeled for Scp3 and Chk1. Chk1 is present
along the synaptonemal complexes and the synapsed region of the sex
chromosomes, but has not yet appeared along the unsynapsed axial
element of the X chromosome (arrowhead). In atm–/– mice (f,g),
progression of meiosis is disrupted as the synaptonemal complexes
begin to fragment following synapsis. Although homologous
chromosomes synapse in atm–/– spermatocytes (large arrow), no Chk1
is detected along the synapsed bivalents (arrowheads) or fragmented
synaptonemal complexes (small arrow in f). The specificity of staining
was confirmed by examining pre-immune serum and by specific and
non-specific peptide block experiments (data not shown).
staging of meiosis I and facilitating the timing of the  asso-
ciation of Chk1 with meiotic chromosomes. Chk1 associ-
ates with synapsed autosomal chromosome axes at a later
stage of meiosis than does Atm (that is, downstream in the
temporal process of meiosis) but co-localizes with Atr on
the unsynapsed arms of the X–Y pair. Given the estab-
lished timing of mammalian meiosis, this indicates a dual
role for Chk1 — acting temporally downstream of Atr and
Atm on autosomes and acting coincidentally with Atr on
the X–Y in mid–late pachytene. A model that integrates
the localization of Atm, Atr and Chk1 on meiotic I auto-
somes and the X–Y is shown in Figure 6.
Chk1 acts temporally downstream from Atm as its appear-
ance on meiotic synaptonemal complexes is temporally
downstream of Atm’s meiotic action-point [10,20].
Further, as shown by three independent experimental
methods (Figures 2–5), Chk1 protein is Atm-dependent.
Therefore, the time of Chk1 appearance on meiotic chro-
mosomes and its dependence on Atm function indicates
that Chk1 is downstream of Atm in a temporal, pro-
grammed, meiotic process. A number of mechanisms
could account for the lack of Chk1 in atm–/– mouse testis
cells. Chk1 transcription could be Atm-dependent, Chk1
protein stability could be Atm-dependent, or the stage of
meiosis when Chk1 acts could be Atm-dependent. If
either Chk1 transcription or protein stability is Atm-depen-
dent, then a lack of Chk1 protein in atm–/– could account
for a G2 defect in atm–/– cells. If the absence of Chk1 in
atm–/– testis is due to the time of action of Chk1, this
might suggest a specific role for mammalian Chk1 in a
DNA-damage-processing checkpoint.
Chk1 localizes to chromosomes that are in the process of
repairing programmed DNA-strand breaks in meiosis
Chk1 in S. pombe responds to DNA damage by signaling
cell-cycle components and halting cell division. The asso-
ciation of Chk1 with chromosomes that may be in the
process of repairing programmed DNA-strand breaks sug-
gests that mammalian Chk1 may have a similar role to S.
pombe Chk1 in meiotic checkpoint signaling. Chk1 is asso-
ciated with synaptonemal complexes (not with the DNA
per se), and late recombination nodules on synaptonemal
complexes are the site of recombination during meiosis I.
Furthermore, programmed DNA-strand breaks initiate
meiotic recombination and are therefore essential for
meiosis to occur. Genetic recombination occurs during
pachytene of meiotic prophase at sites along the synap-
tonemal complex, not in the bulk of the chromatin that
loops out from the synaptonemal complex [49]. Therefore,
the presence of Chk1 at sites along the synaptonemal
complex may be a marker for meiotic breaks that are being
repaired. Further, a temporal analysis of Chk1 in defined
genetic backgrounds that are defective in either a G1
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Table 1
Comparison of Chk1 and Atr localization in meiosis I.
Atr Chk1
Zygonema Foci –
unsynapsed (A + X–Y)
Zygonema – Foci
synapsed (A)
Pachynema – Foci →
synapsed (A) coated axis
Early pachynema Foci → –
unsynapsed (X–Y) coated axis
Mid–late pachnema Coated axis Foci →
unsynapsed (X–Y) coated axis
Column 1 lists the stages at which Chk1 and Atr can be detected on
meiotic chromosomes. During zygonema of meiotic prophase I
homologous autosomes synapse. During this stage unsynapsed and
synapsed autosome axes are present. In pachynema, autosomes are
fully synapsed. The X and Y begin synapsing in pachynema and Chk1
appears as foci along the synapsed autosomes. By mid-pachynema,
Chk1 coats the entire axis. On the X–Y in early pachynema, Chk1 and
Atr can be detected together as foci on unsynapsed X–Y axes. The
foci become continuous as the entire axis becomes coated. 
A = autosomes; X–Y = sex chromosomes.
Figure 5
Coordinate role for Chk1 with Atm. Dependence of Chk1 on functional
Atm. Mouse testis extract (MTE; 50 µg) was analyzed by western
analysis with anti-Chk1. Chk1Mo is designated by the arrow. The blot
was stripped and reprobed with anti-Atr to verify that the protein loads
of each lane were equivalent. Lane 1, Chk1 in atm+/+ p53–/–; lane 2,
lack of Chk1 in atm–/– p53+/–; lane 3, lack of Chk1 in atm–/– p53–/–;
lane 4, Chk1 in an atm+/+ p53+/+ littermate.
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checkpoint protein (p53), or in a broader G1, S and G2
checkpoint regulator (Atm), or in both (atm–/– p53–/–
double-null background), reveals a dependence of one
potential checkpoint protein (Chk1) on the presence of a
second checkpoint protein (Atm). The observation that
the p53 status of the testes does not affect the spatial and
temporal distribution of Chk1 during meiosis is consistent
with the normal fertility, immunological status and devel-
opmental patterns reported from analysis of mice dis-
rupted for p53 [40].
The finding that Chk1 acts downstream of Atm in meiosis
is supported by a number of observations. Atm can be
detected as foci which appear during zygotene, when
homologous autosomal axial elements contact each other
during chromosome synapsis. Atm localization occurs
throughout pachytene and persists on fully-paired biva-
lents [10]. Our data show that the temporal and spatial dis-
tribution of Chk1 is similar to that of Atm, and suggest
that Chk1 is temporally present in similar locations to
Atm. Chk1 appears in a focal pattern along the synapto-
nemal complexes in zygotene (Table 1). By mid-
pachynema, Chk1 coats the synaptonemal complex. The
coincidental temporal pattern of Chk1 and Atm in meiotic
cells and the absence of Chk1 in atm–/– mice satisfies two
major prerequisites for Chk1 to be acting temporally
downstream from Atm. 
We have mapped CHK1 to 11q22–23, which is frequently
deleted in human tumors. This location, in addition to the
role of Chk1 in yeast and mammals in mediating the
response to DNA damage and in regulating Cdc25 [32],
indicates that CHK1 may be a tumor suppressor gene.
Since ATM has been excluded as the tumor suppressor
gene at 11q22–23 [33], a region that is responsible for
marked deletions and loss of heterozygosity in human
tumors, the cell-cycle gene CHK1 remains a strong candi-
date gene for an association with tumors. Mutational
analyses of human tumor samples are being performed to
address this possibility.
Conclusions
We have identified human and mouse homologs of the
fission yeast Chk1 and Drosophila Grp checkpoint protein
kinases and have demonstrated that these are expressed in
the testes and associate with meiotic synaptonemal com-
plexes during zygonema and pachynema. Chk1 acts
genetically and temporally downstream of Atm. Thus, we
conclude that in mammalian cells Chk1 is required to
coordinate recombination and meiotic progression and acts
to integrate signals from Atr and Atm. 
Materials and methods
Isolation of Chk1Hu/Mo
To clone the DNA sequence encoding Chk1Hu, homology between S.
pombe Chk1 and EST H67490 was identified. Continued EST data-
base searching revealed several human sequences that were aligned
into a contig of approximately 1,000 bp. A theoretical contig was
assembled from seven EST clones, producing a 1,000 bp sequence
that contained an open reading frame with homology to S. pombe
Chk1. The clone was extended by RACE (rapid amplification of cDNA
ends) PCR and library screening. Library screening of 1 × 106 indepen-
dent cDNA clones from a human testis unizap library (Clontech)
yielded 11 overlapping sequences that were used to assemble the
CHK1Hu contig. The Chk1Mo was identified by library screening of a
mouse testis cDNA library using a Chk1-specific probe, Genbank
accession numbers AF032875 (Mo); AF032874 (Hu). The primary
sequence data and Chk1 alignment are available as Supplementary
material.
Chromosomal localization of CHK1Hu
The Stanford G3 Radiation Hybrid panel was used to map the location
of CHK1. PCR yielded a unique PCR amplicon with primer 1 (Chk1
30mer 3′-UT) GGCTCTGGGGAATCCTGGTGAATATAGTGCTGC
and primer 2 (Chk1 30mer 3′-UT) TCCCCTGAAACTTGGTTTC-
CACCAGATGAG. Reactions were: one cycle at 94°C for 5 min 
Research Paper  Chk1 interactions with meiotic chromosomes Flaggs et al. 983
Figure 6
Model for Atm, Atr and Chk1 associations
with autosomes and the sex chromosome. 
(a) Role of Chk1 in autosome reactions of
meiotic prophase I. Chk1 foci appear in
zygonema and spread along the entire
chromosome axis as pachynema progresses.
This reaction is Atm-dependent. (b) X–Y
chromosome reactions. Atr and Chk1 co-
localize in mid to late pachynema along
unsynapsed regions of the X–Y chromosomes
after the homologous regions of these
chromosomes pair.
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followed by 40 cycles of denaturing at 94°C for 20 sec, annealing at
65°C for 20 sec, and extension at 72°C for 20 sec. For sublocalization,
chromosome 11 radiation hybrid DNA samples (Research Genetics)
were analyzed and the results were decoded at
http://shgc.stanford.edu/. CHK1Hu localized between D11S1328 and
D11S934, a telomeric region of 11q23.3.
Northern blot hybridization
Northern blots contained 2 µg poly(A)+ RNA and were obtained from
Clontech. A 235 bp PCR product was amplified in the presence of
[32P]-dCTP and [32P]-dTTP using primers HSCHK2: 5′-GTTGCTCCA-
GAACCTCTGAAGA and HSCHK2′: 5′-GCTGATGGATTCTCAAC-
TAAGAT and 100 ng human CHK1 cDNA as a template. For the mouse
probe, oligonucleotides MMCHK1: 5′-GTTGAGACTCCATCAT-
CAAGG and MMCHK1’: 5’-TCTGGCTGGGAACTAGAGAAC were
used to generate an amplicon of 220 bp. PCR conditions were: one
cycle of 8 min at 94°C, 40 cycles of 94°C for 20 sec, 58°C for 20 sec,
and 72°C for 20 sec. Each blot was incubated and washed as recom-
mended by the manufacturer. The final wash was performed at 55°C to
minimize the possibility of cross-hybridization to related sequences. The
northern analyses are available as Supplementary material. 
Generation of monospecific antibodies to Chk1Hu/Mo
Anti-peptide antibodies were generated against human and mouse
Chk1 proteins by coupling of Chk1-specific peptide CLKETFEKL-
GYQWKK (mouse and human common) to keyhole limpet hemocyanin.
To purify the sera by affinity chromatography, 3 ml Thiol coupling gel
(TCGel, Quality Controlled Biochemicals) equilibrated with TEB
(50 mM Tris, 5 mM EDTA-Na, pH 8.5) was mixed with 1.25 mg
peptide. The resin was washed with 10 column volumes of TEB and
treated with blocking buffer (50 mM cysteine in TEB buffer per ml gel).
It was washed with 20 column volumes of salt buffer (500 mM NaCl in
50 mM NaH2PO4, pH 6.5) and 10 column volumes of phosphate buffer
(50 mM NaH2PO4, pH 6.5). A serum sample (20 ml) was loaded,
washed with 10 column vols of salt buffer, and eluted with glycine
buffer (100 mM glycine-HCl, pH 2.5). Fractions containing antibody
were pooled and dialyzed in storage buffer (10 mM NaH2PO4, 20 mM
MgCl2 pH 7.0) and stored at –20°C as αChk1 #2-3.
Immunocytochemistry
Testes from normal and knockout mice were collected and preserved
in Tissue Tek OCT compound. Cryosections (6 µm) were placed in a
50°C oven to dry and fixed in 4°C acetone for 2 min. The slides were
incubated with αChk1 #2-3 (1:100) for 30 min. Goat anti-rabbit
biotinylated antibody (1:200) was applied and incubated for 15 min at
37°C. Goat anti-biotin (1:200) was then applied and incubated for
15 min at 37°C. After each incubation, the slides were rinsed with Tris-
buffered saline (TBS). DAB (3,3’-diaminobenzidine) horseradish peroxi-
dase substrate was used for detection. Reactions were counterstained
with Gill’s hematoxylin. For negative controls, the pre-immune sera
alone and the secondary and tertiary antibodies were assayed: these
did not give any signal.
Meiotic surface-spread preparations
For the meiotic preparations, surface spreads of spermatocytes from
15–21 day-old mice were prepared [50]. Antibody incubation and
detection procedures were a modification of Moens et al. [51]. Since
the antibodies against Chk1 and SCP3 were raised in rabbit, sperma-
tocytes were labeled and imaged sequentially. Goat anti-rabbit
IgG–rhodamine-conjugated and goat anti-rabbit IgG–FITC-conjugated
(Pierce) secondary antibodies were used for detection. No signal was
seen with the pre-immune sera or with Chk1 antisera preincubated with
the immunizing peptide. All preparations were counterstained with 4’,
6’-diamino-2-phenylindole (DAPI, Sigma) and mounted in a DABCO
(Sigma) antifade solution. The preparations were examined on a Zeiss
Axioskop (63-X and 100-X, 1.2 Plan Neofluor oil-immersion objective).
Each fluorochrome (FITC, rhodamine and DAPI) image was captured
separately as an 8-bit source image using a computer-assisted cooled
charge-coupled device camera (Photometrics CH220) and the
separate images were 24-bit pseudocolored and merged with custom
software [52]. 
Immunoprecipitations, protein kinase assays and western blot
analysis
Mouse testis extracts were prepared by grinding testes with liquid
nitrogen. Lysis buffer (50 mM NaPO4 pH 7.2, 0.5% Triton X-100, 
2 mM EDTA, 2 mM EGTA, 25 mM NaF, 25 mM 2-glycerolphosphate,
1 mM phenylmethylsulfonyl fluoride (PMSF), 1 µg ml–1 leupeptin,
1 µg ml–1 pepstatin A, and 2 mM dithiothreitol (DTT)) was added and
the extract was dounced. For Chk1 immunoprecipitates, 400 µg of
extract was incubated with either 10 µg affinity-purified Chk1 #2-3 or
pre-immune serum for 30 min on ice in 1 × TSAT (0.01 M Tris-Cl
pH 8.0, 0.14 M NaCl, 0.024% NaN3, 0.2% Triton X-100. Protein
A–agarose (Pierce) was added and the mixture was incubated for
30 min at 4°C. The immune complex was washed three times in TSAT
and once with kinase buffer (25 µM Hepes pH 7.7; 50 mM KCl; 10 mM
MgCl2; 0.1% NP-40, 2% glycerol, 1 mM DTT, 50 µM ATP), and incu-
bated in kinase buffer containing 10 µCi [γ-32P]-ATP (3000 Ci mmol–1)
for 20 min at 37°C. The reactions were stopped with 20 µl 2 × sodium
dodecyl sulfate (SDS) sample buffer prior to polyacrylamide gel elec-
trophoresis. Reactions were transferred to Immobilon, exposed to film,
then subsequently probed to detect precipitated protein. The non-
immune rabbit IgG (pre-immune) sera and a peptide block with the
immunizing peptide demonstrate the specificity of the Chk1 reagent
(Figure 1a). 
Recombinant Chk1Hu
Chk1Hu DNA was cloned into pGex KGH using the NdeI–SalI sites.
The internal NdeI sites were eliminated by mutagenesis. Extracts of
Escherichia coli transformed with gst–Chk1 were used to prepare
recombinant proteins. Cells were induced with isopropyl β-D-thiogalac-
toside (IPTG), harvested and washed in STE buffer (10 mM Tris
pH 8.0, 150 mM NaCl, 1 mM EDTA). Lysis was with STE with 1 mM
PMSF and 100 µg lysozyme, followed by addition of 5 mM DTT and
1.5% Sarkosyl and sonication. Glutathione–agarose beads, plus 2%
Triton X-100, were added and the beads were pelleted. Bound pro-
teins were eluted with elution buffer (50 mM Tris pH 8.0, 150 mM
NaCl, 1 mM PMSF, 10 mM glutathione).
Preparation of human fibroblast extracts
Human fibroblasts were lysed in 1% NP-40 extraction buffer (1% 
NP-40, 150 mM NaCl, 50 mM Hepes pH 7,4, 25 mM NaF, 25 mM 
β-glycerophosphate, 10 µM orthophosphovanadate, 0.5 mM EGTA,
DNase I, and RNase). Chk1 was immunoprecipitated from 400 µg total
protein. Protein A–Sepharose beads were added and the immune
complexes incubated for 30 min. The immune complexes were washed
three times in NP-40 buffer and twice in Chk1 kinase buffer. Protein
kinase reactions were performed with 5 µl of 1 mg ml–1 MBP.
Supplementary material
Details of the the primary sequence data and Chk1 alignment and of
the northern analyses of Chk1 mRNA are published as Figures S1 and
S2 in the Supplementary material accompanying this paper on the
internet.
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